ENSC Ensysce Biosciences, Inc.
Nasdaq · SEC CIK 1716947 · EDGAR
- Bought, last 12 months
- $444.2K 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 36 since 2021-07-01, latest 2026-08-18 06:06
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| GOWER BOB G | Dir | $444.2K | — |
Transactions 10
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-18 06:06 | 2026-04-23+ | ENSC | GOWER BOB G | Dir | P - Purchase | $0.4888 | +908.6K | 916.7K | +11,182% | +$444.2K |
| 2023-03-06 | 2023-03-02 | ENSC | GOWER BOB G | Dir | P - Purchase | $0.49 | +90.3K | 1.22M | +8% | +$44.2K | |
| M | 2023-03-02 | 2023-02-28+ | ENSC | GOWER BOB G | Dir | P - Purchase | $0.4829 | +379.3K | 1.13M | +50% | +$183.2K |
| D | 2023-02-01 | 2022-12-09 | ENSC | GOWER BOB G | Dir | P - Purchase | $1.40 | +357.1K | 753.1K | +90% | +$500.0K |
| DM | 2022-05-27 | 2022-05-25+ | ENSC | Kirkpatrick Lynn | CEO, Dir | P - Purchase | $0.5011 | +97.0K | 354.9K | +38% | +$48.6K |
| 2021-07-02 | 2021-06-30 | ENSC | Chang William H | Dir, 10% | A - Grant | — | +353.5K | 353.5K | New | — | |
| I | 2021-07-02 | 2021-06-30 | ENSC | Chang William H | Dir, 10% | A - Grant | — | +2.24M | 2.24M | New | — |
| 2021-07-02 | 2021-06-30 | ENSC | Humphrey David Carl | CFO | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 | |
| D | 2021-07-02 | 2021-06-30 | ENSC | GOWER BOB G | Dir, 10% | A - Grant | — | +7.92M | 7.92M | New | — |
| D | 2021-07-02 | 2021-06-30 | ENSC | Kirkpatrick Lynn | CEO, Dir | A - Grant | — | +284.9K | 284.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations